Here, Adrian Vella & team show hepatic resistance to glucagon’s effects on amino acid catabolism is not a significant factor in postprandial metabolism, regardless of obesity or hepatic steatosis: type2diabetes MASH Glucagon.
Address correspondence to: Adrian Vella, Endocrine Research Unit, Mayo Clinic College of Medicine, 200 First St. SW, 5–194 Joseph, Rochester, Minnesota 55,905, USA. Phone: 507.255.6515; Email: [email protected].
Find articles by Christie, H. in: | Google Scholar | 
1Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA.